Focus on developing the platform and new drug formulations
Soidinsalo, however, is not the father of the original idea. That distinction goes to the Chief Scientist of the group, Kuldeep Bansal, who realized the excellent qualities of the jasmine lactone and designed the polymer a couple of years ago. Having conducted polymeric nanomedicine research in Nottingham, England, Bansal moved to Finland for his post-doc studies at Åbo Akademi in Turku.
Around Bansal’s groundbreaking work, a powerful team has formed at Åbo Akademi, with Soidinsalo serving as “entrepreneur in residence,” bringing a business mindset to a science-driven group.
The surprising thing here? – The fact that this startup is not, technically speaking, a startup.
“We haven’t registered the company yet,” confirms Soidinsalo. “Right now, our focus is on studying the polymer and developing the platform and new drug formulations onwards,” Soidinsalo says, adding that setting up a company is something for 2022.